Raymond James, Cantor Bullish on UniQure Following FDA Update

Seeking Alpha02:11

Novartis Touts Encouraging Data From Late-Stage Study For Fabhalta In Rare Type Of Blood Disorder

BenzingaDec 7 02:10

PTC Therapeutics: Hold Rating Amid Strategic Collaboration With Novartis and Clinical Uncertainties

TipRanksDec 6 13:55 · Ratings

Citi Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Raises Target Price to $32

Futu NewsDec 6 00:35 · Ratings

PTC Therapeutics(PTCT.US) Officer Sells US$5.02 Million in Common Stock

$PTC Therapeutics(PTCT.US)$ Officer Boulding Mark Elliott sold 95,908 shares of common stock on Dec 2, 3, 2024 at an average price of $52.37 for a total value of $5.02 million.Source: Announcement

Futu NewsDec 5 06:23

PTC Therapeutics(PTCT.US) Officer Sells US$3.73 Million in Common Stock

$PTC Therapeutics(PTCT.US)$ Officer Almstead Neil Gregory sold 71,610 shares of common stock on Dec 2, 2024 at an average price of $52.06 for a total value of $3.73 million.Source: Announcement What

Futu NewsDec 5 06:23